Suppr超能文献

具有有序三级分类终点的非劣效性试验设计与分析

Noninferiority trial design and analysis with an ordered three-level categorical endpoint.

作者信息

Brittain Erica, Hu Zonghui

机构信息

Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, USA.

出版信息

J Biopharm Stat. 2009 Jul;19(4):685-99. doi: 10.1080/10543400902964142.

Abstract

This paper extends standard methodology for noninferiority trial design from a binary endpoint to an ordered three-level endpoint, such as "success," "intermediate," and "failure." A metric that summarizes outcome on this endpoint is proposed, and the corresponding sample size requirements are presented. This ordered endpoint can be collapsed into two different binary endpoints, respectively lumping "intermediate" outcomes with "success" or with "failure." We describe how the ordered three-level endpoint compares with these two binary endpoints with respect to the noninferiority margin and sample size requirements.

摘要

本文将非劣效性试验设计的标准方法从二元终点扩展到有序三级终点,如“成功”“中等”和“失败”。提出了一种总结该终点结果的指标,并给出了相应的样本量要求。这个有序终点可以分别合并为两个不同的二元终点,即将“中等”结果与“成功”或“失败”归为一类。我们描述了有序三级终点在非劣效性界值和样本量要求方面与这两个二元终点的比较情况。

相似文献

1
Noninferiority trial design and analysis with an ordered three-level categorical endpoint.
J Biopharm Stat. 2009 Jul;19(4):685-99. doi: 10.1080/10543400902964142.
2
Test Statistics and Confidence Intervals to Establish Noninferiority between Treatments with Ordinal Categorical Data.
J Biopharm Stat. 2015;25(5):921-38. doi: 10.1080/10543406.2014.920865. Epub 2014 Jun 11.
3
Sample size computation for two-sample noninferiority log-rank test.
J Biopharm Stat. 2005;15(6):969-79. doi: 10.1080/10543400500265736.
6
Test for the consistency of noninferiority from multiple clinical trials.
J Biopharm Stat. 2007;17(2):265-78. doi: 10.1080/10543400601177400.
7
Mixed noninferiority margin and statistical tests in active controlled trials.
J Biopharm Stat. 2007;17(2):339-57. doi: 10.1080/10543400601183861.
8
Bayesian sample size determination for a clinical trial with correlated continuous and binary outcomes.
J Biopharm Stat. 2013;23(4):790-803. doi: 10.1080/10543406.2013.789885.
9
Corrected profile likelihood confidence interval for binomial paired incomplete data.
Pharm Stat. 2013 Jan-Feb;12(1):48-58. doi: 10.1002/pst.1551. Epub 2013 Jan 7.

本文引用的文献

1
Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment of patients with community-acquired pneumonia.
Clin Microbiol Infect. 2004 Jun;10(6):512-20. doi: 10.1111/j.1469-0691.2004.00875.x.
2
Some fundamental issues with non-inferiority testing in active controlled trials.
Stat Med. 2003 Jan 30;22(2):213-25. doi: 10.1002/sim.1315.
4
Choosing an equivalence limit for noninferiority or equivalence studies.
Control Clin Trials. 2002 Feb;23(1):2-14. doi: 10.1016/s0197-2456(01)00196-9.
6
"Proving the null hypothesis" in clinical trials.
Control Clin Trials. 1982 Dec;3(4):345-53. doi: 10.1016/0197-2456(82)90024-1.
7
Randomized, double-blind trial of cefonicid and nafcillin in the treatment of skin and skin structure infections.
Antimicrob Agents Chemother. 1990 Apr;34(4):654-6. doi: 10.1128/AAC.34.4.654.
9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验